Exemestane, sold under the brand name Aromasin, is a medication used primarily in the treatment of breast cancer. It belongs to a class of drugs known as aromatase inhibitors, which work by lowering estrogen levels in the body. Estrogen can promote the growth of certain types of breast cancer cells, so reducing its production is a key strategy in treating hormone-receptor-positive breast cancer.
Exemestane is often prescribed to postmenopausal women who have already undergone surgery, radiation, or other cancer treatments to prevent recurrence. It is also used in cases where cancer has spread to other parts of the body (metastatic breast cancer). Unlike other aromatase inhibitors, such as anastrozole or letrozole, exemestane is a steroidal inhibitor, meaning it permanently binds to the aromatase enzyme, leading to a more sustained suppression of estrogen production.
The drug is typically taken orally once a day, and common side effects include hot flashes, fatigue, joint pain, and an increased risk of osteoporosis due to the reduction in bone density. In some cases, exemestane can also lead to more severe side effects like liver function changes, high cholesterol, or cardiovascular issues, so regular monitoring by a healthcare professional is recommended.
Exemestane is not usually prescribed to premenopausal women because their ovaries still produce significant amounts of estrogen, which the drug cannot effectively suppress. Additionally, it is important to note that exemestane should not be taken in conjunction with estrogen-containing medications, as they would counteract its effects.
Overall, exemestane is a crucial tool in the ongoing management of breast cancer, offering a targeted approach to reducing estrogen levels and helping to improve long-term outcomes for patients.
https://www.hormonerawsource.com/steroid-finished-us-domestic-shipping/steroid-finished-tablets-3-days-to-arrive/fierce-exemestane-aromasin-for-bodybuilting.html
